Acusphere Goes Public, NDA In Sight For Myocardial Perfusion Imaging Agent
This article was originally published in The Gray Sheet
Executive Summary
Acusphere expects to file a new drug application for its AI-700 enhanced ultrasound contrast agent no later than 2005